Aspira Women's Health Inc.
AWHL· OTC
Released Aug 9, 2017, after the close
10-Q filed Aug 11, 2017, 42 days after period end · 0000926617-17-000049
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $898.00K | $709.00K | $535.00K | $324.00K |
| Net Income | -$2.36M | -$3.75M | -$4.85M | -$5.56M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.07 |
| -$0.11 |
| -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.